The company is developing an anonymized, deidentified data platform that will be used to gain clinical insights and discover new treatments. The tool will be offered to tech, biopharma and other healthcare companies.
“Culmination Bio was built to expand on the success of Intermountain’s precision medicine efforts by creating longitudinal, multimodal data sets,” said Lincoln Nadauld, MD, PhD, CEO of Culmination and a former vice president and chief of precision health at Intermountain, in a March 17 news release. “Culmination’s powerful insights platform will unlock the next generation of discoveries to advance healthcare.”
Intermountain Ventures, the health system’s venture capital arm, helped propel the new company.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
